Label12 (Label12)
Hydralazine Hydrochloride Tablet
Product Images NDC 70518-2551
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydralazine Hydrochloride (NDC 70518-2551). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Remedy_label (Remedy Label)
This is a description of a medication called hydrALAZINE HCI in the form of a tablet containing 25mg of the substance. The medication is available in a bottle with 30 tablets each. It includes details such as the NDC number, expiration date, and lot number. The manufacturer of the medication is Camber Pharma, Inc, located in Piscataway, N.J 08854. The medication should be kept out of the reach of children, and the package insert should be consulted for directions for use. RemedyRepack Inc., Indiana, P.A 15701, was responsible for repackaging the medication. The medication should be stored at a temperature of 20-26°C (63-77°F), with allowed excursions ranging from 15-30°C (59-86°F) [See USP].*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
